APTUS Biotech
PrediApt
Biomarkers / Diagnostic
Cancer
Aptusbiotech is developing two prognostic applications in response to platinum derivative treatment in lung cancer using MAFG as diagnostic biomarker and based on aptamers
2Preclinical Validation,
1R+D
Spain